Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes

被引:113
|
作者
Swiryn, Steven [1 ]
Orlov, Michael V. [2 ]
Benditt, David G. [3 ]
DiMarco, John P. [4 ]
Lloyd-Jones, Donald M. [1 ]
Karst, Edward [5 ]
Qu, Fujian [5 ]
Slawsky, Mara T. [6 ]
Turkel, Melanie [5 ]
Waldo, Albert L. [7 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
[3] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[4] Univ Virginia, Charlottesville, VA USA
[5] St Jude Med, Sunnyvale, CA USA
[6] Tufts Univ, Sch Med, Baystate Med Ctr, Springfield, MA 01199 USA
[7] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA
关键词
anti-coagulation; atrial fibrillation; defibrillators; pacemakers; stroke; trials; TEMPORAL RELATIONSHIP; RISK-FACTOR; STROKE; EVENTS; DURATION;
D O I
10.1161/CIRCULATIONAHA.115.020252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The RATE Registry (Registry of Atrial Tachycardia and Atrial Fibrillation Episodes) is a prospective, outcomes-oriented registry designed to document the prevalence of atrial tachycardia and/or fibrillation (AT/AF) of any duration in patients with pacemakers and implantable cardioverter defibrillators (ICDs) and evaluate associations between rigorously adjudicated AT/AF and predefined clinical events, including stroke. The appropriate clinical response to brief episodes of AT/AF remains unclear. Methods: Rigorously adjudicated electrogram (EGM) data were correlated with adjudicated clinical events with logistic regression and Cox models. Long episodes of AT/AF were defined as episodes in which the onset and/or offset of AT/AF was not present within a single EGM recording. Short episodes of AT/AF were defined as episodes in which both the onset and offset of AT/AF were present within a single EGM recording. Results: We enrolled 5379 patients with pacemakers (N=3141) or ICDs (N=2238) at 225 US sites (median follow-up 22.9 months). There were 359 deaths. There were 478 hospitalizations among 342 patients for clinical events. We adjudicated 37531 EGMs; 50% of patients had at least one episode of AT/AF. Patients with clinical events were more likely than those without to have long AT/AF (31.9% vs. 22.1% for pacemaker patients and 28.7% vs. 20.2% for ICD patients; P<0.05 for both groups). Only short episodes of AT/AF were documented in 9% of pacemaker patients and 16% of ICD patients. Patients with clinical events were no more likely than those without to have short AT/AF (5.1% vs. 7.9% for pacemaker patients and 11.5% vs. 10.4% for ICD patients; P=0.21 and 0.66, respectively). Conclusions: In the RATE Registry, rigorously adjudicated short episodes of AT/AF, as defined, were not associated with increased risk of clinical events compared with patients without documented AT/AF. Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00837798.
引用
收藏
页码:1130 / 1140
页数:11
相关论文
共 50 条
  • [1] Clinical Implications of Device-Detected Atrial Tachyarrhythmias: Results From the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the Cardiac Rhythm Management Device Population (RATE)
    Swiryn, Steven
    Benditt, David G.
    DiMarco, John P.
    Lloyd-Jones, Donald M.
    Orlov, Michael V.
    Slawsky, Mara T.
    Turkel, Melanie
    Waldo, Albert L.
    CIRCULATION, 2012, 126 (23) : 2792 - 2792
  • [2] Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the cardiac rhythm management device population: The RATE Registry Design
    Waldo, Albert L.
    Benditt, David G.
    DiMarco, John P.
    Lloyd-Jones, Donald M.
    Orlov, Michael V.
    Slawsky, Mara T.
    Swiryn, Steven
    AMERICAN HEART JOURNAL, 2009, 157 (06) : 983 - U5
  • [3] Toward More Personalized Management of Device-Detected Atrial Fibrillation
    Siegler, James E.
    Sposato, Luciano A.
    Yaghi, Shadi
    JAMA NEUROLOGY, 2024, 81 (06) : 573 - 574
  • [4] Device-detected atrial tachyarrhythmias: what do we know?
    Healey, Jeff S.
    EUROPACE, 2012, 14 (02): : 157 - 158
  • [5] Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation
    Sanders, Prashanthan
    Svennberg, Emma
    Diederichsen, Soren Z.
    Crijns, Harry J. G. M.
    Lambiase, Pier D.
    Boriani, Giuseppe
    Van Gelder, Isabelle C.
    EUROPEAN HEART JOURNAL, 2024, 45 (29) : 2594 - 2603
  • [6] Device-Detected Atrial Fibrillation Evidencing the Knowledge Gap
    Mulder, Bart A.
    Van Gelder, Isabelle C.
    Rienstra, Michiel
    CIRCULATION, 2019, 139 (22) : 2513 - 2515
  • [7] Racial Differences in Device-Detected Incident Atrial Fibrillation
    Goergen, Jack A.
    Peigh, Graham
    Varberg, Nathan
    Ziegler, Paul D.
    Roberts, Anthony I.
    Stanelle, Evan
    Soderlund, Dana
    Khan, Sadiya S.
    Passman, Rod S.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2025, 11 (02) : 298 - 308
  • [8] Device-Detected Atrial Fibrillation-Perils and Pitfalls: An Update
    Surapaneni, Phani
    Safadi, Abdul
    Contractor, Tahmeed
    Patel, Mehul B.
    Thakur, Ranjan K.
    CARDIOLOGY CLINICS, 2016, 34 (02) : 299 - +
  • [9] Device-Detected Subclinical Atrial Fibrillation as Fire Under the Ashes
    Park, Seung-Jung
    KOREAN CIRCULATION JOURNAL, 2023, 53 (07) : 497 - 498
  • [10] Anticoagulation for patients with device-detected atrial fibrillation and a history of stroke
    Sposato, Luciano A.
    Wachter, Rolf
    LANCET NEUROLOGY, 2025, 24 (02): : 92 - 94